StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report released on Sunday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
Athersys has a 12-month low of $0.01 and a 12-month high of $1.99. The firm has a market capitalization of $833,000.00, a P/E ratio of -0.01 and a beta of -0.90.
Athersys Company Profile
Further Reading
- Five stocks we like better than Athersys
- Top Biotech Stocks: Exploring Innovation Opportunities
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- How to Use High Beta Stocks to Maximize Your Investing Profits
- AMD Gains Momentum With AI: Can It Beat Expectations?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.